Gary Skole’s Post

View profile for Gary Skole, graphic

Owner at AlzBetter LLC

🚨 Major Update in Alzheimer's Diagnosis 🚨 The Alzheimer's Association has released new criteria for diagnosing Alzheimer's disease, sparking debate in the medical community. Key points: New criteria incorporate advanced lab work Potential for earlier diagnosis and treatment Concerns raised about over-diagnosis and pharmaceutical influence This update is likely to increase Alzheimer's diagnoses significantly. While early detection can open new treatment avenues, some worry about unnecessary labeling. Adding to the controversy: The approval board includes pharmaceutical industry representatives FDA's approval of Eli Lilly's early Alzheimer's treatment, donanemab, followed shortly after What are your thoughts on this development? How might it impact patients, healthcare providers, and the pharmaceutical industry? This link to a CNN Health article has more details: https://lnkd.in/eDfsSkcP #Alzheimers #Healthcare #MedicalEthics #Neuroscience

Jerry Rothkoff

Managing Attorney of Rothkoff Law Group, an Elder Care Law Firm

16h
Like
Reply
Alterman, LCSW Nancy

Liscensed Clinical Social Worker

4d

Yes. Many other possiblililities need to be ruled out. Blood work and MRI required as well

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics